Advertisement

Topics

Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration to Evaluate ...

02:06 EDT 31 Jul 2017 | BioMedReports - Blog
Phase 2 Trial will Evaluate Opdivo in Combination with Rubraca and Other Compounds in Metastatic Castration-Resistant Prostate Cancer

Read more...

Original Article: Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration to Evaluate ...

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration to Evaluate ..."

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...